Farheen Sultana

Title: Farheen Sultana: Innovator in Anticancer Research

Introduction

Farheen Sultana is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of potential anticancer agents. With a total of 2 patents, Sultana's work is paving the way for new therapeutic options in cancer treatment.

Latest Patents

Sultana's latest patents include innovative compounds that show promise in combating cancer. The first patent involves 3-(4-ethylnylphenyl) pyridopyrimidinone compounds, which have demonstrated promising anticancer activity in sixty human cancer cell lines. This invention provides a new avenue for potential anticancer agents that could significantly impact treatment protocols. The second patent focuses on 3-arylethynyl substituted quinazolinone compounds, which are also aimed at targeting cancer cells effectively. These compounds have been formulated to enhance their efficacy against various cancer types.

Career Highlights

Farheen Sultana is affiliated with the Council of Scientific & Industrial Research, where he conducts his research. His work is characterized by a strong focus on developing compounds that can serve as effective treatments for cancer. Sultana's innovative approach and dedication to research have positioned him as a key figure in his field.

Collaborations

Sultana collaborates with talented individuals such as Ahmed Kamal and Ranjita Nayak, who contribute to his research endeavors. Their combined expertise enhances the potential for groundbreaking discoveries in the realm of anticancer agents.

Conclusion

Farheen Sultana's contributions to anticancer research through his innovative patents highlight the importance of continued exploration in medicinal chemistry. His work not only showcases his inventiveness but also offers hope for future advancements in cancer treatment.